CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Common Shares of Cascadia Minerals Ltd.